NCT02278302View on ClinicalTrials.gov

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

March 31, 2000

Conditions
Healthy
Interventions
DRUG

Aggrenox®

DRUG

Placebo

OTHER

Ethanol

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02278302 - Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers | Biotech Hunter | Biotech Hunter